Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population
VaxInnate
VaxInnate : Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population
2 other identifiers
observational
410
0 countries
N/A
Brief Summary
In this study, the poly vaccination of military personnel prior to deployment will be analyzed in terms of central, peripheral and long-lasting changes in innate immunity. Analysis of monocyte immune training induced by vaccination will provide a better understanding of the indirect effects of vaccination and their persistence over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedNovember 1, 2023
October 1, 2023
2.4 years
October 26, 2023
October 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Monocytes' functional reprogramming
describing the functional reprogramming of monocytes following vaccination sessions among military personnel prior and after deployment
11 months
Secondary Outcomes (2)
Identify immune signatures
11 months
Time persistence
11 months
Study Arms (2)
Sampling and survey group
This group will complete questionnaires and participate in sample collection.
Survey group
This group will only complete questionnaires
Interventions
Collecting data on infectious diseases during the study period
Eligibility Criteria
The study population is composed by healthy subjects which have to receive a vaccine update in order to be deployed
You may qualify if:
- french military personnel
- \>18yo
- overseas deployment scheduled between 30 and 60 days after vaccination session
- adult
- able to give consent
You may not qualify if:
- unrectified military personnel
- pregnancy or breastfeeding
- vaccine contraindication
- major incapacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
Blood sample and saliva sample
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 1, 2023
Study Start
November 1, 2023
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
November 1, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share